Active Biotech's election committee appointed

Active Biotech's election committee appointed

ID: 508612

(Thomson Reuters ONE) -



PRESS RELEASE

In accordance with a decision made by the Annual General Meeting held on May
26, 2016, the Election Committee shall comprise the representatives for the
three largest shareholders, as per end of September 2016, and the Chairman of
the Board.

For the 2017 Annual General Meeting, the Election Committee shall propose Board
members and a Chairman of the Board, and fees to Board members and auditors. The
following individuals were appointed representatives for the largest
shareholders and, accordingly, are members of the Election Committee:

Johnny Sommarlund, MGA Holding
Tomas Billing, Nordstjernan
Lennart Johansson, Investor

Under the leadership of the Chairman of the Board, Mats Arnhög, the Election
Committee shall prepare proposals to be presented to and decided upon at the
Annual General Meeting on June 15 2017.

Lund, November 22, 2016
Active Biotech AB (publ)

Tomas Leanderson
President and CEO

Active Biotech AB (publ) (NASDAQ Stockholm: ACTI) is a biotechnology company
with focus on neurodegenerative/inflammatory diseases and cancer. Laquinimod, an
orally administered small molecule with unique immunomodulatory properties, is
in pivotal Phase 3 development for the treatment of relapsing remitting multiple
sclerosis. Also, laquinimod is in Phase 2 development for the treatment of
primary progressive multiple sclerosis and Huntington's disease. Furthermore,
commercial activities are conducted for the tasquinimod, paquinimod och SILC
projects. Please visit www.activebiotech.com for more information.

Active Biotech AB
(Corp. Reg. No. 556223-9227)
Box 724, SE-220 07 Lund, Sweden
Tel: +46 (0)46 19 20 00



161122_Active Biotech's election committee appointed:
http://hugin.info/1002/R/2058599/771520.pdf







This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Active Biotech via GlobeNewswire




Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  SSDLP - Seadrill Partners LLC Announces Third Quarter 2016 Results KalVista Pharmaceuticals Announces Closing of Merger with Carbylan Therapeutics
Bereitgestellt von Benutzer: hugin
Datum: 22.11.2016 - 15:05 Uhr
Sprache: Deutsch
News-ID 508612
Anzahl Zeichen: 2482

contact information:
Town:

LUND



Kategorie:

Business News



Diese Pressemitteilung wurde bisher 244 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Active Biotech's election committee appointed"
steht unter der journalistisch-redaktionellen Verantwortung von

Active Biotech (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Active Biotech's election committee appointed ...

In accordance with a decision made by the Annual General Meeting held on May 7, 2009, the Election Committee shall comprise the representatives for the three largest shareholders on September 30 and the Board Chairman. For the 2010 Annual General ...

Active Biotech AB Interim Report, January - September 2009 ...

* Laquinimod -- new data presented at ECTRIMS * 57-57 -- exploratory clinical trial in progress * RhuDex(TM) -- clinical development to continue following feedback from UK MHRA * ANYARA -- complete Phase I data published * TASQ -- complete Phase I ...

Alle Meldungen von Active Biotech



 

Werbung



Sponsoren

foodir.org The food directory für Deutschland
News zu Snacks finden Sie auf Snackeo.
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z